Challenges implementing technology transfer as a viable pathway for equitable vaccine production and access: A case study of the mRNA vaccine hub in South Africa
In the face of the COVID-19 pandemic, there have been renewed calls for more equitable vaccine access. These calls have in turn resulted in interventions to increase vaccine manufacturing capacity as one of the key interventions to address global vaccine access. However, skill gaps in manufacturing...
Saved in:
| Main Authors: | Omowamiwa Kolawole, Caroline Ncube, Jeremy de Beer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Global Public Health |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/17441692.2025.2504698 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Embedding a commitment to equitable global access into basic and early-phase translational research
by: Barry S. Coller
Published: (2025-01-01) -
The Patent System During Global Pandemic and the Access to Medications and Vaccines
by: Fatou Diagne Mbaye, et al.
Published: (2022-01-01) -
Patent suspension on the COVID-19 vaccine in Indonesian patent law perspective
by: Vania Lutfi Safira Erlangga, et al.
Published: (2023-12-01) -
COVID-19 and Equitable Distribution of Vaccine: Emerging Debates within the Framework of the World Trade Organization Agreements
by: Meltem Sarıbeyoğlu Skalar
Published: (2021-12-01) -
Entrevista. Las patentes y la pandemia, entrevista con Arjun Jayadev
by: Leopoldo Gómez-Ramírez
Published: (2021-01-01)